tradingkey.logo

Mira Pharmaceuticals Announces Approval And Initiation Of Phase 1 Clinical Trial For Ketamir-2 In Neuropathic Pain

ReutersMar 4, 2025 2:14 PM

- Mira Pharmaceuticals Inc MIRA.O:

  • MIRA PHARMACEUTICALS ANNOUNCES APPROVAL AND INITIATION OF PHASE 1 CLINICAL TRIAL FOR KETAMIR-2 IN NEUROPATHIC PAIN

Source text: [ID:n0001493152-25-008977]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI